{
    "nctId": "NCT05427071",
    "briefTitle": "Magnetic Marker Localization for Occult Breast Cancer and Target Axillary Dissection in Node-positive Breast Cancer Post-neoadjuvant Chemotherapy",
    "officialTitle": "Magnetic Marker Localization for Occult Breast Cancer and Target Axillary Dissection in Node-positive Breast Cancer Post-neoadjuvant Chemotherapy",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Neoplasm, Chemotherapy Effect",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Successful localization of breast tumor and axillary lymph node",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* All patients with cT1-3N1 invasive ductal carcinoma planned for neoadjuvant chemotherapy and/or target therapy\n* mentally competent to give informed consent\n* Agreed to proceed with curative operation after chemotherapy and tentatively keen for breast conservative surgery and targeted axillary dissection after neoadjuvant chemotherapy\n* Radiologically 1-3 ipsilateral axillary lymph node metastases confirmed by cytology or biopsy\n\nExclusion Criteria:\n\n* Presence of distant metastasis, inflammatory breast cancers, multi-centric breast cancers\n* History of previous ipsilateral axillary surgery or irradiation\n* Hypersensitivity to dextran compounds or iron\n* Iron overload disease\n* Pregnant or lactating patients\n* Patients with pacemaker or other implantable metallic devices in chest wall or prosthesis in shoulder\n* Mentally incompetent patients",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}